The Antimicrobial Resistance Challenge
Antibiotic resistance is a serious public health threat that demands immediate action from all sectors of society. So that's why we're excited to join The Global Antimicrobial Resistance Challenge, an initiative led by the U.S. Centers for Disease Control and Prevention (CDC) and U.S. Department of Health and Human Services that launches today during the United Nations General Assembly. The challenge calls on governments, private industry and civil society to commit to taking actionable steps that further progress in combating antibiotic resistance around the world.
Antibiotic-resistant infections are becoming increasingly common, and if we don’t change course, it is estimated that by 2050, antibiotic-resistant infections will kill 10 million people per year worldwide – that’s roughly one person dying every three seconds.
What is the Antibiotic Resistance Action Center doing to help fight antibiotic resistance?
- We are conducting cutting-edge research to understand the major drivers of antibiotic-resistant infections and how to stop them.
- We are working with health care providers to educate clinicians and patients to use antibiotics more responsibly.
- We are working with food companies to develop market-based solutions to reduce unnecessary antibiotic use in food animals.
- We are disseminating information and educating the public and policymakers about antibiotic resistance.
Learn more about our work by visiting our website, www.battlesuperbugs.com
Does Your Organization Want to Make a Commitment?
The AMR Challenge is a way for governments, private industries, and non-governmental organizations worldwide to make formal commitments that further the progress against antibiotic resistance. The challenge encourages a One Health approach, recognizing that the health of people is directly connected to the health of animals and the environment.
Organizations can make commitments until September 2019. CDC will feature commitments throughout the year. At the 2019 UN General Assembly, antibiotic resistance will continue to be a priority topic for world leaders.